S. 3656 · 117th Congress
Reducing Hereditary Cancer Act of 2022
- Stage
- In committee
- Sponsor
- Lisa Murkowski
- Introduced
- 2022-02-16
- Latest action
- 2022-02-16 · Introduced in Senate
Summary
Reducing Hereditary Cancer Act of 2022
This bill provides for Medicare coverage of germline mutation testing for individuals with a personal or family history of a hereditary cancer gene mutation or suspected history of hereditary cancer, as well as for associated coverage of risk-reducing surgeries and screenings.